178 related articles for article (PubMed ID: 31277963)
1. Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.
Chiba T; Nakano M; Hasebe Y; Kimura Y; Fukasawa K; Miki K; Morosawa S; Takanami K; Ota H; Fukuda K; Shimokawa H
J Cardiol; 2020 Jan; 75(1):34-41. PubMed ID: 31277963
[TBL] [Abstract][Full Text] [Related]
2. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis.
Di Stefano C; Bruno G; Arciniegas Calle MC; Acharya GA; Fussner LM; Ungprasert P; Cooper LT; Blauwet LA; Ryu JH; Pellikka PA; Carmona Porquera EM; Villarraga HR
BMC Cardiovasc Disord; 2020 Jan; 20(1):21. PubMed ID: 31959111
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function.
Kiehl EL; Makki T; Kumar R; Gumber D; Kwon DH; Rickard JW; Kanj M; Wazni OM; Saliba WI; Varma N; Wilkoff BL; Cantillon DJ
Heart Rhythm; 2016 Dec; 13(12):2272-2278. PubMed ID: 27855853
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
[TBL] [Abstract][Full Text] [Related]
8. Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.
Sekihara T; Nakane E; Nakasone K; Inoko M
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797880
[TBL] [Abstract][Full Text] [Related]
9. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
10. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
11. Risk of Adverse Cardiovascular Events in Cardiac Sarcoidosis Independent of Left Ventricular Function.
Rosenthal DG; Cheng RK; Petek BJ; Masri SC; Mikacenic C; Raghu G; Patton KK
Am J Cardiol; 2020 Jul; 127():142-148. PubMed ID: 32402485
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
Nordenswan HK; Lehtonen J; Ekström K; Kandolin R; Simonen P; Mäyränpää M; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006145. PubMed ID: 30354309
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis.
Kobayashi Y; Nagai T; Takenaka S; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Tsujinaga S; Iwano H; Kusano K; Yasuda S; Ogawa H; Ishibashi-Ueda H; Anzai T
Am J Cardiol; 2021 Aug; 152():125-131. PubMed ID: 34127248
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular global longitudinal strain provides prognostic value incremental to left ventricular ejection fraction in patients with heart failure.
Motoki H; Borowski AG; Shrestha K; Hu B; Kusunose K; Troughton RW; Tang WH; Klein AL
J Am Soc Echocardiogr; 2014 Jul; 27(7):726-32. PubMed ID: 24679740
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Impact of Right Ventricular Pacing on Left Ventricular Systolic Function in Pacemaker Recipients With Preserved Ejection Fraction: Results From a Large Single-Center Registry.
Ebert M; Jander N; Minners J; Blum T; Doering M; Bollmann A; Hindricks G; Arentz T; Kalusche D; Richter S
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27444509
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy.
Cho SW; Gwag HB; Hwang JK; Chun KJ; Park KM; On YK; Kim JS; Park SJ
Eur J Heart Fail; 2019 May; 21(5):643-651. PubMed ID: 30734436
[TBL] [Abstract][Full Text] [Related]
18. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
19. A new risk score for ventricular tachyarrhythmia in acute myocardial infarction with preserved left ventricular ejection fraction.
Lee SH; Jeong MH; Kim JH; Kim MC; Sim DS; Hong YJ; Ahn Y; Chae SC; Seong IW; Park JS; Chae JK; Hur SH; Cha KS; Kim HS; Gwon HC; Seung KB; Rha SW;
J Cardiol; 2018 Nov; 72(5):420-426. PubMed ID: 29779893
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
